Orzolol Ophthalmic Solution

Strength
2%+0.5%
(0 reviews)

In-house product


Price
৳550.00 /pc
Quantity
(100 available)
Total Price
Share

Offer

Alternative Products

Indications

This sterile eye drops is indicated for the treatment of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta blockers.

Interaction

Additive hypotension and bradycardia with oral calcium channel blockers, catecholamine-depleting drugs or β-blockers, antiarrhythmics (e.g. amiodarone), digitalis glycosides, parasympathomimetics, narcotics and MAOIs. Additive systemic side effects with oral carbonic anhydrase or β-blockers; avoid concurrent use. Additive systemic β-blockade with CYP2D6 inhibitors (e.g. quinidine, SSRIs) and timolol.

Contraindications

Contraindicated in patients who are hypersensitive to any of the components of this preparation.

Side Effects

Mild burning, ocular hyperemia, blurred vision may occur.

Dosage

Instill one drop in the conjunctival sac of the affected eye(s) twice daily.Use in children: Safety and effectiveness in children below the age of 2 years have not been established. Use in elderly patients: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.

Administration

n/a

Pregnancy Cat

Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. This Eye Drops should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Use in lactation: Caution should be exercised when This Eye Drops is administered to a nursing mother.

Precautions

For ophthalmic use only. Patients should remove their contact lenses prior to instilling this preparation and should not insert their lenses until 15 minutes after instillation of the preparation.

Overdose Effects

n/a

Drug Classes

Drugs for miotics and glaucoma

Storage Conditions

Store in a cool & dry place, protect from light. Do not use longer than one month after first opening. Keep out of the reach of children.

Composition

n/a

Mode Of Action

Dorzolamide Hydrochloride and Timolol Maleate reduce intraocular pressure (IOP) by combined action. Dorzolamide is human carbonic anhydrase II inhibitor which decreases aqueous humor secretion by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Timolol is a non-selective beta adrenergic receptor blocker that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane stabilizing) activity. It lowers IOP by decreasing the formation of aqueous humor in the ciliary epithelium.

Reconstitution

n/a

Frequently Bought Products

Reviews & Ratings

0 out of 5.0
(0 reviews)
There have been no reviews for this product yet.

Product Queries (0)

Login or Registerto submit your questions to seller

Other Questions

No none asked to seller yet

Alternative Products